L C Bidwell1, E A Henry2, E G Willcutt2, M K Kinnear2, T A Ito2. 1. Center for Alcohol and Addition Studies, Department of Psychiatry and Human Behavior, Brown University, Box G-S121-4, Providence, RI 02912, United States; Rhode Island Hospital, Department of Psychiatry, Division of Behavioral Genetics, 1 Hoppin Street, Providence, RI 02903, United States. Electronic address: cinnamon_bidwell@brown.edu. 2. Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, United States.
Abstract
BACKGROUND: Numerous studies have shown that attention deficit/hyperactivity disorder (ADHD) is associated higher risk of cannabis use disorders (CUD). However, these studies are limited in that most did not: (a) differentiate the role of hyperactivity-impulsivity (HI) and inattention (IN); (b) control for associated psychopathology; and (c) consider more fine-grained CUD-related measures. Our aim was to clarify the unique and interactive contributions of inattention and hyperactivity symptoms to age of cannabis initiation and DSM-IV cannabis dependence, craving, and severity of problems related to cannabis use while statistically controlling for symptoms of comorbid psychopathology in a non-clinical sample of young adults. METHODS: Cannabis variables, current use of cigarettes and alcohol, current and childhood ADHD, and comorbid internalizing and externalizing psychopathology were assessed in 376 male and female undergraduates. RESULTS: Results indicate that current and childhood IN were independently associated with more severe cannabis use, craving, and problem use-related outcomes in young adulthood (p's<.01) and that childhood HI symptoms were associated with earlier initiation of cannabis (p<.01). Further, current IN symptoms moderated the relationships between level of use and more severe outcomes (p's<.01), such that higher IN strengthened positive associations among use and problem cannabis use. Associations with ADHD symptom dimensions and current use of alcohol and cigarettes were also present. CONCLUSIONS: Thus, current and childhood inattention symptoms as well as childhood hyperactive-impulsive symptoms emerged as significant factors in cannabis-related outcomes in young adults, even after statistically controlling for important confounding variables.
BACKGROUND: Numerous studies have shown that attention deficit/hyperactivity disorder (ADHD) is associated higher risk of cannabis use disorders (CUD). However, these studies are limited in that most did not: (a) differentiate the role of hyperactivity-impulsivity (HI) and inattention (IN); (b) control for associated psychopathology; and (c) consider more fine-grained CUD-related measures. Our aim was to clarify the unique and interactive contributions of inattention and hyperactivity symptoms to age of cannabis initiation and DSM-IV cannabis dependence, craving, and severity of problems related to cannabis use while statistically controlling for symptoms of comorbid psychopathology in a non-clinical sample of young adults. METHODS: Cannabis variables, current use of cigarettes and alcohol, current and childhood ADHD, and comorbid internalizing and externalizing psychopathology were assessed in 376 male and female undergraduates. RESULTS: Results indicate that current and childhood IN were independently associated with more severe cannabis use, craving, and problem use-related outcomes in young adulthood (p's<.01) and that childhood HI symptoms were associated with earlier initiation of cannabis (p<.01). Further, current IN symptoms moderated the relationships between level of use and more severe outcomes (p's<.01), such that higher IN strengthened positive associations among use and problem cannabis use. Associations with ADHD symptom dimensions and current use of alcohol and cigarettes were also present. CONCLUSIONS: Thus, current and childhood inattention symptoms as well as childhood hyperactive-impulsive symptoms emerged as significant factors in cannabis-related outcomes in young adults, even after statistically controlling for important confounding variables.
Authors: J-B Pingault; S M Côté; C Galéra; C Genolini; B Falissard; F Vitaro; R E Tremblay Journal: Mol Psychiatry Date: 2012-06-26 Impact factor: 15.992
Authors: Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Margaret A Keyes; Matt McGue; William G Iacono Journal: Drug Alcohol Depend Date: 2017-12-27 Impact factor: 4.492
Authors: Elizabeth T C Lippard; Carolyn M Mazure; Jennifer A Y Johnston; Linda Spencer; Judah Weathers; Brian Pittman; Fei Wang; Hilary P Blumberg Journal: J Neurosci Res Date: 2017-01-02 Impact factor: 4.164
Authors: Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Sylia Wilson; Matt McGue; William G Iacono Journal: Drug Alcohol Depend Date: 2020-02-27 Impact factor: 4.492
Authors: Tashia Petker; Mark Ferro; Michael Van Ameringen; James Murphy; James MacKillop Journal: Psychopharmacology (Berl) Date: 2021-02-27 Impact factor: 4.530
Authors: Daniel P Notzon; John J Mariani; Martina Pavlicova; Andrew Glass; Amy L Mahony; Daniel J Brooks; John Grabowski; Frances R Levin Journal: Am J Addict Date: 2016-11-11
Authors: Daniel P Notzon; Martina Pavlicova; Andrew Glass; John J Mariani; Amy L Mahony; Daniel J Brooks; Frances R Levin Journal: J Atten Disord Date: 2016-03-31 Impact factor: 3.256
Authors: Jill A Rabinowitz; Rashelle J Musci; Adam J Milam; Kelly Benke; George R Uhl; Danielle Y Sisto; Nicholas S Ialongo; Brion S Maher Journal: Drug Alcohol Depend Date: 2018-08-25 Impact factor: 4.492